BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26219246)

  • 1. The prothrombotic activity of cancer cells in the circulation.
    Mitrugno A; Tormoen GW; Kuhn P; McCarty OJ
    Blood Rev; 2016 Jan; 30(1):11-9. PubMed ID: 26219246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
    Grover SP; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):709-725. PubMed ID: 29437578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8(th) Symposium on Hemostasis: Translational and Basic Science Discoveries.
    Margaritis P; Key NS
    Thromb Res; 2016 May; 141 Suppl 2():S1-3. PubMed ID: 27207413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
    Mackman N; Tilley RE; Key NS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and thrombosis in women - molecular mechanisms.
    Rickles FR
    Thromb Res; 2009; 123 Suppl 2():S16-20. PubMed ID: 19217469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor: (patho)physiology and cellular biology.
    Eilertsen KE; Østerud B
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):521-38. PubMed ID: 15389118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Insights Into the Regulation of Coagulation and Thrombosis.
    Li X; Sim MMS; Wood JP
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):e119-e125. PubMed ID: 32320291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated Thrombosis.
    Campello E; Henderson MW; Noubouossie DF; Simioni P; Key NS
    Thromb Haemost; 2018 Feb; 118(2):251-265. PubMed ID: 29378353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability.
    Liu S; Zhang Y; Zhao X; Wang J; Di C; Zhao Y; Ji T; Cheng K; Wang Y; Chen L; Qi Y; Li S; Nie G
    Nano Lett; 2019 Jul; 19(7):4721-4730. PubMed ID: 31180684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.
    Pepke W; Eisenreich A; Jaster M; Ayral Y; Bobbert P; Mayer A; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2013 Apr; 31(2):115-23. PubMed ID: 22212466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis.
    Rondon AMR; Kroone C; Kapteijn MY; Versteeg HH; Buijs JT
    Semin Thromb Hemost; 2019 Jun; 45(4):396-412. PubMed ID: 31096312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Tissue Factor in the Coagulation Network.
    Cimmino G; Ciccarelli G; Golino P
    Semin Thromb Hemost; 2015 Oct; 41(7):708-17. PubMed ID: 26408920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.
    Chu AJ
    Front Biosci; 2006 Jan; 11():256-71. PubMed ID: 16146730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor.
    Kakkar AK; DeRuvo N; Chinswangwatanakul V; Tebbutt S; Williamson RC
    Lancet; 1995 Oct; 346(8981):1004-5. PubMed ID: 7475548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting clotting proteins in cancer therapy - progress and challenges.
    Ruf W; Rothmeier AS; Graf C
    Thromb Res; 2016 Apr; 140 Suppl 1(Suppl 1):S1-7. PubMed ID: 27067961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol pathways in the regulation of tissue factor prothrombotic activity.
    Versteeg HH; Ruf W
    Curr Opin Hematol; 2011 Sep; 18(5):343-8. PubMed ID: 21778880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prothrombotic state in cancer: pathogenic mechanisms.
    De Cicco M
    Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.
    Rothmeier AS; Marchese P; Langer F; Kamikubo Y; Schaffner F; Cantor J; Ginsberg MH; Ruggeri ZM; Ruf W
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1323-1331. PubMed ID: 28495929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.